MomGuard IMS Plus
This podcast introduces the IMS Plus screening test, designed to detect inherited metabolic diseases and congenital hearing loss in newborns at an early stage.
This podcast episode was prepared with AI assistance. The expressions in the content may occasionally have shortcomings or linguistic errors. The information here is for general informational purposes only; it does not constitute a diagnosis or treatment recommendation. For any evaluation and decision regarding your health condition, please consult your physician or Omega Genetik Diagnostic Evaluation Center.
About the Episode
This podcast introduces the IMS Plus screening test, designed to detect inherited metabolic diseases and congenital hearing loss in newborns at an early stage. Developed by LabGenomics, this test uses Next Generation Sequencing (NGS) technology to analyze thousands of pathogenic mutations across 27 different genes. The scope includes critical conditions such as lysosomal storage diseases, glycogen storage diseases, Wilson's disease, and various hearing disorders. The documents highlight the advantages of early diagnosis in halting disease progression and planning appropriate treatment, with results delivered within ten business days of sample collection. Additionally, the test's technical limitations, accuracy rate, and need for genetic counseling are presented in both Turkish and English formats. Sample test reports illustrate the analyzed genes, quality control standards, and how findings are clinically interpreted.